These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 30676535

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Adverse effects of cannabinoids.
    Anciones C, Gil-Nagel A.
    Epileptic Disord; 2020 Jan 01; 22(S1):29-32. PubMed ID: 31941644
    [Abstract] [Full Text] [Related]

  • 24. Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy.
    Samanta D.
    Pediatr Neurol; 2019 Jul 01; 96():24-29. PubMed ID: 31053391
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Investigational cannabinoids in seizure disorders, what have we learned thus far?
    Ružić Zečević D, Folić M, Tantoush Z, Radovanović M, Babić G, Janković SM.
    Expert Opin Investig Drugs; 2018 Jun 01; 27(6):535-541. PubMed ID: 29842819
    [Abstract] [Full Text] [Related]

  • 29. Cannabinoids and Epilepsy.
    Rosenberg EC, Tsien RW, Whalley BJ, Devinsky O.
    Neurotherapeutics; 2015 Oct 01; 12(4):747-68. PubMed ID: 26282273
    [Abstract] [Full Text] [Related]

  • 30. Cannabinoid treatments in epilepsy and seizure disorders.
    Devinsky O, Jones NA, Cunningham MO, Jayasekera BAP, Devore S, Whalley BJ.
    Physiol Rev; 2024 Apr 01; 104(2):591-649. PubMed ID: 37882730
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pharmacology and drug interactions of cannabinoids.
    Landmark CJ, Brandl U.
    Epileptic Disord; 2020 Jan 01; 22(S1):16-22. PubMed ID: 31941642
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cannabis constituents reduce seizure behavior in chemically-induced and scn1a-mutant zebrafish.
    Thornton C, Dickson KE, Carty DR, Ashpole NM, Willett KL.
    Epilepsy Behav; 2020 Sep 01; 110():107152. PubMed ID: 32585475
    [Abstract] [Full Text] [Related]

  • 37. The cannabidiol conundrum: potential benefits and risks of cannabidiol products for children.
    Singer L, Tokish H, Park F, Campisi C, Milanaik RL.
    Curr Opin Pediatr; 2020 Feb 01; 32(1):198-205. PubMed ID: 31833952
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Cannabidiol for Epilepsy: New Hope on the Horizon?
    Sanmartin PE, Detyniecki K.
    Clin Ther; 2018 Sep 01; 40(9):1438-1441. PubMed ID: 30150078
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.